Investor Relations Home

Webcast - Live Q4 2009 AngioDynamics Earnings Conference Call 07/16/09 at 4:30 p.m. ET Webcast - Replay AngioDynamics at JMP Securities LLC Research Conference 05/19/09 at 11:30 a.m. PT The Company AngioDynamics designs, develops, manufactures, and markets a diversified line of innovative therapeutic and diagnostic medical devices that enable interventional physicians to effectively treat peripheral vascular disease (PVD) and other non-coronary diseases. Interventional radiologists and vascular surgeons use AngioDynamic’s devices in minimally invasive, image-guided procedures to treat narrowed, obstructed, or ballooned peripheral arteries or veins, and non-cardiac organs. Major product lines include angiographic catheters, hemodialysis catheters, image-guided vascular access products, an endovascular laser venous system to treat varicose veins, and drainage products. The Company sells its products in the U.S. directly and in 34 international markets through a distributor network. More >> Recent News More News >> Date Title   07/02/09 Angiodynamics Offers New, High Flexibility Rfa Device For Cancer Tumor Ablation 07/02/09 AngioDynamics to Hold Fiscal 2009 Fourth Quarter and Full Year Financial Results Conference Call on July 16, 2009 05/14/09 AngioDynamics to Participate in the Eighth Annual JMP Securities Research Conference 05/11/09 Jan Keltjens Appointed to Board of Directors of AngioDynamics

Stock Quote ANGO (Common) Exchange NASDAQ (US Dollar) Price $12.97 Change (%)   0.17 (1.29%) Volume 187,509 Data as of 07/06/09 4:00 p.m. ET Minimum 20 minute delay Refresh quote Featured Reports   Form 10-Q (Q3 FY 2009)   Form 10-Q (Q2 FY 2009)   Form 10-Q (Q1 FY 2009)   Form 10-K (FY 2008)   Form 10-Q (Q3 FY 2008)   Form 10-Q (Q2 FY 2008)   Form 10-Q (Q1 FY 2008) Receive E-mail Alerts Sign up to receive e-mail alerts whenever AngioDynamics posts new information to the site. Just enter your e-mail address and click submit.